Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Chembio Diagnostics, Inc. logo — company profile

Chembio Diagnostics, Inc.

Founded 1986 United States Medford, United States 117 employees Biotechnology, Health Care +1

General Information

Company Name Chembio Diagnostics, Inc.
Founded Year 1986
Location United States Medford, United States +1
Employees 117
Industries Biotechnology, Health Care, Manufacturing
Social

Get notified when Chembio Diagnostics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. is a prominent point-of-care diagnostics company established in 1986, with a focus on delivering rapid and accurate disease tests such as STIs and COVID-19. The company's FDA CLIA Waiver for the rapid point-of-care combination test for HIV & Syphilis marks a significant milestone. Chembio's DPP® technology platform, known for its high-quality and rapid results, caters to a wide range of applications beyond infectious diseases. With global distribution to various healthcare entities, including hospitals, clinics, and public health organizations, Chembio offers a comprehensive range of diagnostic solutions. The DPP platform's ability to provide up to eight distinct test results from a single patient sample, combined with the convenience of the DPP Micro Reader optical analyzer, positions Chembio as an innovative player in the decentralized testing space. The company's dedication to expediting diagnosis and treatment aligns with the growing demand for accessible and efficient healthcare solutions. For more information, visit www.chembio.com.

Taxonomy: diagnostics, point-of-care testing, rapid testing, infectious diseases, HIV, Syphilis, COVID-19, FDA, CLIA Waiver, DPP technology, multiplexing, portable testing, decentralized testing, public health

No funding data available for Chembio Diagnostics, Inc. yet.

Get notified when Chembio Diagnostics, Inc. raises funding

Chembio Diagnostics, Inc. Alternatives & Competitors

Chembio Diagnostics, Inc. vs
AgenDx Biosciences
AgenDx Biosciences

AgenDx is an early stage molecular diagnostics company developing a cost-effective platform for mole...

Seed
Health Care
Chembio Diagnostics, Inc. vs
Radisens Diagnostics
Radisens Diagnostics

Empowering physicians with instant, comprehensive point-of-care diagnostics to bridge diagnostic gap...

Grant
Health Care
Chembio Diagnostics, Inc. vs
Anavasi Diagnostics®
Anavasi Diagnostics® United States

Rapidly detecting the presence of RNA with breakthrough molecular technology.

Convertible Note
26 employees
Biotechnology, Manufacturing

FAQ About Chembio Diagnostics, Inc.

About Chembio Diagnostics: Chembio is a leading point-of-care diagnostics company focused on creating fast actionable tests to diagnose diseases quickly and accurately, including STIs and COVID-19, enabling expedited treatment. Chembio tests are easy to use and provide results in approximately 15 mi...
Chembio Diagnostics, Inc. was founded in 1986.
Chembio Diagnostics, Inc. is headquartered in Medford, United States.
Chembio Diagnostics, Inc. operates in the following industries: Biotechnology, Health Care, Manufacturing.
Chembio Diagnostics, Inc. has approximately 117 employees.
Top alternatives and competitors to Chembio Diagnostics, Inc. include AgenDx Biosciences, Radisens Diagnostics, Anavasi Diagnostics®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chembio Diagnostics, Inc. and AgenDx Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Chembio Diagnostics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy